Early malaria infection, dysregulation of angiogenesis, metabolism and inflammation across pregnancy, and risk of preterm birth in Malawi: A cohort study.
BACKGROUND:Malaria in pregnancy is associated with adverse birth outcomes. However, the underlying mechanisms remain poorly understood. Tight regulation of angiogenic, metabolic, and inflammatory pathways are essential for healthy pregnancies. We hypothesized that malaria disrupts these pathways lea...
Main Authors: | Robyn E Elphinstone, Andrea M Weckman, Chloe R McDonald, Vanessa Tran, Kathleen Zhong, Mwayiwawo Madanitsa, Linda Kalilani-Phiri, Carole Khairallah, Steve M Taylor, Steven R Meshnick, Victor Mwapasa, Feiko O Ter Kuile, Andrea L Conroy, Kevin C Kain |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-10-01
|
Series: | PLoS Medicine |
Online Access: | https://doi.org/10.1371/journal.pmed.1002914 |
Similar Items
-
Sequential disruptions to inflammatory and angiogenic pathways and risk of spontaneous preterm birth in Malawian women
by: Andrea M. Weckman, et al.
Published: (2023-06-01) -
Neurocognitive outcomes in Malawian children exposed to malaria during pregnancy: An observational birth cohort study.
by: Andrea M Weckman, et al.
Published: (2021-09-01) -
Scheduled Intermittent Screening with Rapid Diagnostic Tests and Treatment with Dihydroartemisinin-Piperaquine versus Intermittent Preventive Therapy with Sulfadoxine-Pyrimethamine for Malaria in Pregnancy in Malawi: An Open-Label Randomized Controlled Trial.
by: Mwayiwawo Madanitsa, et al.
Published: (2016-09-01) -
Intestinal barrier disruption with Plasmodium falciparum infection in pregnancy and risk of preterm birth: a cohort studyResearch in context
by: Julie K. Wright, et al.
Published: (2023-11-01) -
Intermittent screening and treatment with artemisinin-combination therapy versus intermittent preventive treatment with sulphadoxine-pyrimethamine for malaria in pregnancy: a systematic review and individual participant data meta-analysis of randomised clinical trials
by: Julie R Gutman, et al.
Published: (2021-11-01)